Camlin Fine Sciences (Small Cap - High Growth) Share Target 2025, 2026 To 2035
|
Camlin Fine Sciences Limited |
|||
|
Price: ₹128.65 (-1.01%) | ||
| 52 Week Low: ₹79.95 52 Week High: ₹141.66 |
|||
| Market Capital: 1,933.22 Crore (Smallcap) | |||
| Basic Materials -> Specialty Chemicals | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Camlin Fine Sciences Share Price Target For 2025
- 1.1.1: Camlin Fine Sciences Share Price Target Table For 2025
- 1.1.2: Short-Term Technical Outlook
- 1.2: Camlin Fine Sciences Share Price Target For 2026
- 1.2.1: Camlin Fine Sciences Share Price Target Table For 2026
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Camlin Fine Sciences Share Price Target Chart and Table From 2025, 2026, 2027 to 2035
- 3: Camlin Fine Sciences Brief Company Overview
- 4: Camlin Fine Sciences Financial Performance
- 4.0.1: Is Camlin Fine Sciences A Good Buy For Long Term?
Camlin Fine Sciences, a Small Cap company in the Specialty Chemicals Industry has delivered 64.6% returns in 5-year, making it a High Growth stock.
To predict the Camlin Fine Sciences's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Camlin Fine Sciences Share Price Target For 2025
The line chart displays the monthly closing prices of Camlin Fine Sciences with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Camlin Fine Sciences shares in 2025, see the table below.
Camlin Fine Sciences Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 141.0 (+9.59%) | Price Action: Sep 2022 High |
| 2025 Target 2 | 139.4 (+8.35%) | Price Action: Dec 2017 High |
| 2025 Target 1 | 137.95 (+7.22%) | Price Action: 04 Dec 2023 High |
| Current Price | 128.65 | Camlin Fine Sciences's share price as of 23 Jan 2025 |
| Stop Loss 1 | 124.33 (-3.36%) | Price Action: 30 Jul 2024 High |
| Stop Loss 2 | 122.95 (-4.44%) | Price Action: 25 Nov 2024 High |
| Stop Loss 3 | 121.2 (-5.8%) | Price Action: Nov 2015 High |
Short-Term Technical Outlook
Current Technical Position: Camlin Fine Sciences is showing mixed momentum signals near key moving averages.
Key Technical Level: The 25-day moving average at ₹131.6 serves as the nearest technical reference point.
Historical Returns: 3-month: +22.91% | 6-month: +6.16% | 1-year: -0.62%
Camlin Fine Sciences Share Price Target For 2026
The line chart displays the monthly closing prices of Camlin Fine Sciences with a black line. The green line shows three potential target prices for 2026, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Camlin Fine Sciences shares in 2026, see the table below.
Camlin Fine Sciences Share Price Target Table For 2026
| Level | Value | Analysis |
|---|---|---|
| 2026 Target 3 | 203.47 (+58.15%) | Price Action: Chart |
| 2026 Target 2 | 199.68 (+55.21%) | Price Action: Chart |
| 2026 Target 1 | 197.7 (+53.67%) | Fibonacci Extension Level 64.90% |
| Current Price | 128.65 | Camlin Fine Sciences's share price as of 23 Jan 2025 |
| Stop Loss 1 | 99.9 (-22.35%) | Price Action: 26 Mar 2024 High |
| Stop Loss 2 | 98.7 (-23.29%) | Price Action: 04 Apr 2024 Low |
| Stop Loss 3 | 97.45 (-24.26%) | Price Action: 07 Jun 2024 High |
Long-Term Technical Outlook
52-Week Range Analysis: Camlin Fine Sciences is currently trading near its 52-week high of ₹141.66, showing strong yearly momentum.
Long-Term Trend Analysis: The stock is maintaining a bullish long-term trend, trading above both 150-day and 250-day moving averages.
Long-Term Performance: 1-year: -0.62% | 3-year: -15.11% | 5-year: +64.62%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Camlin Fine Sciences Share Price Target Chart and Table From 2025, 2026, 2027 to 2035
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹128.65 | ||
| 2025 | ₹169.14 | +31.47% | ₹171.68 |
| 2026 | ₹185.88 | +9.89% | ₹188.67 |
| 2027 | ₹201.89 | +8.61% | ₹204.92 |
| 2028 | ₹206.70 | +2.38% | ₹209.80 |
| 2029 | ₹238.92 | +15.58% | ₹242.50 |
| 2030 | ₹270.91 | +13.38% | ₹274.97 |
| 2031 | ₹282.15 | +4.14% | ₹286.38 |
| 2032 | ₹297.48 | +5.43% | ₹301.94 |
| 2033 | ₹333.02 | +11.94% | ₹338.02 |
| 2034 | ₹369.50 | +10.95% | ₹375.04 |
| 2035 | ₹386.06 | +4.48% | ₹391.85 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Camlin Fine Sciences Brief Company Overview
Camlin Fine Sciences Limited: A Leading Specialty Chemicals Company Camlin Fine Sciences Limited is a renowned specialty chemicals company with a global presence. Since its inception in 1931, Camlin has been at the forefront of research, development, and manufacturing of...
high-quality chemical solutions. The company's diverse product portfolio includes shelf-life solutions, aroma ingredients, pharmaceutical and nutraceutical products, and performance chemicals. Its products are widely used in industries such as food and beverage, pet food, pharmaceuticals, and aroma technical. Camlin's commitment to innovation and quality has earned it a strong reputation in the industry. Camlin is known for its Xtendra and NaSure brands of shelf-life solutions, which provide antioxidants, mold inhibitors, and other additives to extend the shelf life of various products. The company's aroma ingredients, including vanillin and ethyl vanillin, are used in fragrances and flavors worldwide. Camlin's commitment to sustainability and regulatory compliance sets it apart in the market. The company is ISO 9001, ISO 14001, and FSSC 22000 certified, ensuring the highest standards of quality and safety.Camlin Fine Sciences Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 1,933.22 Crore | Market valuation of Camlin Fine Sciences's shares. |
| Revenue (TTM) | 1,589.31 Crore | Total revenue generated by Camlin Fine Sciences over the past twelve months. |
| Net Income (TTM) | -142.26 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | +2.09% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | -8.96% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
-5.7% | Change in revenue compared to the previous quarter. |
| Debt-to-Equity (D/E) Ratio |
79.7 | Company's total debt divided by total shareholder equity. |
| Total Debt | 683.03 Crore | Sum of Camlin Fine Sciences's current & long-term financial obligations. |
| Total Cash | 80.25 Crore | Total amount of liquid funds available to Camlin Fine Sciences. |
| Beta | 1.08 | Beta is greater than 1 indicating that the Camlin Fine Sciences's price is more volatile than the market. |
Is Camlin Fine Sciences A Good Buy For Long Term?
Camlin Fine Sciences, a small-cap stock with a market capitalization of ₹1,933.22 crore, presents a mixed picture for long-term investment. While its 5-year return of 119.37% is impressive, the current scenario shows a net loss of ₹142.26 crore (TTM) and a negative profit margin of -8.96%. High debt (₹683.03 crore) against low cash reserves (₹80.25 crore) further raises concerns. Although recent 6-month returns are positive (12.99%), the overall trend (YTD -11.64%, past 12 months -16.64%) is negative. Therefore, it's currently not a good buy for long-term investment; further analysis is recommended.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
